Gastroesophageal Reflux Disease (GERD) Segmentation: Document How Swiss General Practitioners (GPs) Allocate Their GERD Patients to the Three GERD Patient Segments

Completed

• Conditions: GERD

• Registration Number: NCT00688675
• Lead Sponsor: AstraZeneca

Brief Summary

Document how Swiss GPs allocate their GERD patients to the three GERD patient segments (according to King et al.) and how treated GERD patients are affected by their GERD treatment

Detailed Description

Not available

Study Timeline

• Study Start: 2008-02
• Study First Submitted: 2008-05-29
• Study First Submitted QC: 2008-06-02
• Study First Posted: 2008-06-03
• Primary Completion: 2008-08
• Study Completion: 2008-08
• Status Verified: 2010-12
• Last Update Submitted: 2010-12-06
• Last Update Posted: 2010-12-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2912

Inclusion Criteria

• Previously diagnosed GERD patients
• on treatment for at least 2 weeks

Read More

Exclusion Criteria

• none

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
% patients per GERD patient segment	single visit

Secondary Outcome Measures

Name	Time	Method
Symptom load	single visit
Quality of life	single visit

Trial Locations

Locations (1)

Research Site; 🇨🇭 Aarau, Switzerland